These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17006322)

  • 1. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches.
    McDonald SP; Russ GR
    Transplantation; 2006 Sep; 82(6):759-62. PubMed ID: 17006322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA-matching effect in different cohorts of kidney transplant recipients.
    Terasaki PI
    Clin Transpl; 2000; ():497-514. PubMed ID: 11512361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
    Heise ER; Thacker LR; MacQueen JM; Peters TG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts.
    Krieger NR; Becker BN; Heisey DM; Voss BJ; D'Alessandro AM; Becker YT; Odorico JS; Kalayoglu M; Pirsch JD; Sollinger HW; Knechtle SJ
    Transplantation; 2003 May; 75(10):1677-82. PubMed ID: 12777855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.